Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 14/20 | 0.40 |
| ▸ | JAK2 | O60674 | 6/20 | 0.33 |
| ▸ | JAK1 | P23458 | 6/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21775411 | 0.76 | KDM1A (0.41) | KDM1AJAK2JAK1 | |
| SCHEMBL21775398 | 0.75 | KDM1A (0.37) | KDM1AJAK2JAK1 | |
| SCHEMBL16989462 | 0.66 | KDM1A (0.41) | KDM1AJAK2JAK1 | |
| SCHEMBL18820434 | 0.64 | KDM1A (0.42) | KDM1AJAK1 | |
| Hydrochloric Acid SCHEMBL21775423 | 0.63 | KDM1A (0.41) | KDM1AJAK1 | |
| SCHEMBL26927404 | 0.61 | HSD11B1 (0.35) | — | |
| SCHEMBL21788635 | 0.61 | KDM1A (0.42) | KDM1AJAK2JAK1 | |
| SCHEMBL21784420 | 0.60 | KDM1A (0.41) | KDM1A | |
| SCHEMBL16989418 | 0.59 | KDM1A (0.55) | KDM1AJAK2JAK1 | |
| SCHEMBL17009075 | 0.59 | MMP2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10968200-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | INCYTE CORPORATION (US) | 2021-04-06 | — | — | US | disclosed |
| US-20200071289-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | WILMINGTON PHARMATECH | 2020-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200071289-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | KDM1A, KDM1B, KDM2A | KDM1A 1/4885JAK2 441/4885JAK1 864/4885 |
| US-10968200-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | KDM1A, KDM1B, KDM2A | KDM1A 1/4885JAK2 441/4885JAK1 864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.